Feed CLGN
CL

CollPlant Biotechnologies Ltd.

CLGN · NASDAQ

$4.12 +2.74% (+$0.11)
1M +33.77%
Market Cap $5.34M
P/E Ratio -
Div. Yield -
ROE 160.28%
Piotroski F-Score Weak
1/9
Valuation
50 /100
Fair
P/B 1.09x
P/S 13.73x
PEG N/A
Growth
78 /100
Growing
Book val. growth 42.68%
Rev. growth 99.41%
FCF growth N/A
Profitability
0 /100
Weak
FCF margin 2,982.55%
Op. margin 3,329.05%
Gross margin 319.28%
Quality
1 /100
Poor
Asset turnover 0.04x
ROA 143.03%
ROIC 171.87%
Debt
60 /100
Moderate
Current ratio 2.27x
Int. coverage -57.12x
Debt/Equity 0.54x
Stability
26 /100
Unstable
Profitable years 0
EPS volatility 105.23%
Beta 0.74x

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o CLGN
Online

O podjetju

CollPlant Biotechnologies Ltd. (CLGN) is a biotechnology company operating in the field of regenerative medicine. The company focuses on the development and production of biological materials and collagen-based products for the treatment of various health conditions. CollPlant employs advanced technologies in creating bioinks and 3D printing for tissue and organ generation. The company emphasizes innovation and product development that could contribute to improvements in patient care. CollPlant Biotechnologies Ltd. (CLGN) shares could be an intriguing choice for investors interested in the biotechnology sector and regenerative medicine.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Biotechnology

CEO

Yehiel Tal

Employees

39

Headquarters

Rehovot

Prihajajoči dogodki

02 DEC.

Earnings

Upcoming earnings report

68d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.